Skip to main content

Cardlytics Inc

For the period ended Dec 31, 2023. Filed Mar 14, 2024.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2023 · Filed Mar 14, 2024

CDLX$1.63-10.4%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Consolidated Statements of Stockholders’ Equity

Year Ended December 31, 2023:

AdditionalPaid-InCapital · AccumulatedOtherComprehensiveIncome (loss) · AccumulatedDeficit · Total
Common Stock
Shares · Amount
Balance – December 31, 202233,477$9$1,182,568$5,598$(976,570)$211,605
Exercise of common stock options10—54——54
Stock-based compensation——43,466——43,466
Issuance of restricted stock2,930—————
Issuance of common stock2,755—15,171——15,171
Issuance of common stock under the ESPP556—2,335——2,335
Other comprehensive income———(3,131)—(3,131)
Net loss————(134,702)(134,702)
Balance – December 31, 202339,728$9$1,243,594$2,467$(1,111,272)$134,798

Year Ended December 31, 2022:

AdditionalPaid-InCapital · AccumulatedOtherComprehensiveIncome (loss) · AccumulatedDeficit · Total
Common Stock
Shares · Amount
Balance – December 31, 202133,534$9$1,212,823$486$(522,618)$690,700
Cumulative effect upon adoption of ASU——(51,417)—11,312(40,105)
Exercise of common stock options23—418——418
Stock-based compensation——46,810——46,810
Issuance of restricted stock986—————
Common stock to be issued for the acquisition of Entertainment173—11,937——11,937
Issuance of common stock under the ESPP167—1,997——1,997
Repurchase and cancellation of common stock(1,406)—(40,000)——(40,000)
Other comprehensive loss———5,112—5,112
Net loss————(465,264)(465,264)
Balance – December 31, 202233,477$9$1,182,568$5,598$(976,570)$211,605

CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

Year Ended December 31, 2021:

AdditionalPaid-InCapital · AccumulatedOtherComprehensiveIncome (loss) · AccumulatedDeficit · Total
Common Stock
Shares · Amount
Balance – December 31, 202027,861$8$551,429$(192)$(394,053)$157,192
Exercise of common stock options141—2,155——2,155
Stock-based compensation——50,224——50,224
Issuance of restricted stock724—————
Issuance of common stock3,8501484,048——484,049
Common stock to be issued for the acquisition of Dosh916—117,349——117,349
Fair value of assumed Dosh options attributable to pre-combination service——3,593——3,593
Fair value of assumed Bridg options attributable to pre-combination service——841——841
Issuance of common stock under the ESPP42—3,184——3,184
Other comprehensive loss———678—678
Net loss————(128,565)(128,565)
Balance – December 31, 202133,534$9$1,212,823$486$(522,618)$690,700
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.